Back
Xcelerate, Inc. 10K Form
Sell
11
XCRT
Xcelerate, Inc.
Last Price:
$0.0100
Seasonality Move:
29.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XCRT News And Ratings
See the #1 stock for the next 7 days that we like better than XCRT
XCRT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $-81.7K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Xcelerate, Inc. Earnings Forecast
Key Xcelerate, Inc. Financial Ratios
-
The Research & Development expenses have been 0.00% of Revenue.
-
Per Share Earnings over the last 20 years have been positive in 7 years.
Xcelerate, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | XCRT |
| Website: | xcelerate.global |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XCRT Technical Analysis vs Fundamental Analysis
Sell
11
Xcelerate, Inc. (XCRT)
is a Sell
Is Xcelerate, Inc. a Buy or a Sell?
-
Xcelerate, Inc. stock is rated a SellThe current Xcelerate, Inc. [XCRT] share price is $0.0099. The Score for XCRT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.